Echinococcus multilocularis in Dogs and Foxes: Alveolar Echinococcosis and Zoonotic Risk

Introduction

Echinococcus multilocularis is a small taeniid cestode of the family Taeniidae, recognized as the etiological agent of alveolar echinococcosis (AE) in its definitive and intermediate hosts [1, 2]. Unlike Echinococcus granulosus, which causes cystic echinococcosis, E. multilocularis is characterized by a predominantly sylvatic life cycle involving wild canids, primarily red foxes (Vulpes vulpes), as definitive hosts and a range of small arvicolid rodents as intermediate hosts [3, 4]. The parasite is of significant veterinary and public health concern due to its potential to cause severe, progressive hepatic disease in accidental intermediate hosts, including domestic dogs and humans [5, 6]. This article provides a detailed, publication-grade review of the biology, epidemiology, pathogenesis, molecular diagnostics, and zoonotic risk associated with E. multilocularis in dogs and foxes, with a strict focus on veterinary and diagnostic science.

Life Cycle and Definitive Host Biology

The life cycle of E. multilocularis is obligately two-host, requiring a definitive carnivore host and an intermediate rodent host [7, 8]. Adult tapeworms reside in the small intestine of the definitive host, which includes red foxes, arctic foxes (Vulpes lagopus), and, increasingly, domestic dogs (Canis lupus familiaris) and other canids such as coyotes (Canis latrans) and golden jackals (Canis aureus) [9, 10]. The adult worm is typically 1.2 to 4.5 mm in length, consisting of a scolex with four suckers and a rostellum armed with 28 to 34 hooks, a short neck, and 2 to 6 proglottids [11, 12]. The terminal gravid proglottid contains a uterus filled with eggs, each measuring 30 to 38 micrometers in diameter [13, 14].

Eggs are shed into the environment via definitive host feces. The prepatent period in canids is approximately 28 to 35 days, although variations exist depending on the parasite strain and host immune status [15, 16]. Upon ingestion by a suitable intermediate host (e.g., Microtus spp., Arvicola spp., Ondatra zibethicus), the oncosphere hatches in the small intestine, penetrates the intestinal wall, and migrates via the portal circulation to the liver [17, 18]. In the intermediate host, the metacestode stage develops as a multivesicular, infiltrating mass composed of numerous small cysts (alveoli) that lack a limiting laminated layer, in contrast to E. granulosus [19, 20]. This proliferative growth is characterized by exogenous budding and continuous infiltration of surrounding hepatic parenchyma [21, 22].

Pathogenesis in Dogs: Alveolar Echinococcosis

While dogs serve as definitive hosts for the adult tapeworm, they can also act as aberrant intermediate hosts, developing alveolar echinococcosis following ingestion of E. multilocularis eggs [23, 24]. This dual role is critical for understanding the zoonotic risk, as infected dogs can directly contaminate the peridomestic environment with eggs [25, 26]. Canine AE is a progressive, infiltrative hepatic disease that is often clinically silent until advanced stages [27, 28]. The metacestode mass in dogs is typically located in the liver, with potential extension to the peritoneum, lungs, and other organs [29, 30]. Clinical signs in dogs with hepatic AE include lethargy, anorexia, abdominal distension, hepatomegaly, and, in some cases, icterus [31, 32]. Advanced disease may lead to portal hypertension, ascites, and biliary obstruction [33, 34]. Diagnostic imaging, particularly computed tomography (CT), reveals characteristic hypodense, non-enhancing hepatic masses with peripheral calcification and central necrosis [35, 36]. The CT appearance of canine hepatic AE is distinct from that of cystic echinococcosis, showing a multiloculated, infiltrative pattern without a well-defined capsule [37, 38].

Zoonotic Risk and Transmission Dynamics

The zoonotic risk of E. multilocularis is primarily associated with the accidental ingestion of eggs shed by infected definitive hosts [39, 40]. Humans are dead-end intermediate hosts, and AE in humans is a severe, potentially fatal disease characterized by a tumor-like, infiltrative hepatic lesion that can metastasize to the lungs and brain [41, 42]. The primary risk factor for human infection is direct or indirect contact with infected canid feces, particularly in hyperendemic regions of the Northern Hemisphere, including central Europe, Asia, and North America [43, 44]. Dogs, especially those with access to rodent prey, are considered a high-risk bridge between sylvatic and domestic cycles [45, 46]. Studies have demonstrated that dogs can harbor patent intestinal infections with E. multilocularis without showing clinical signs, making them a silent source of environmental contamination [47, 48]. The prevalence of E. multilocularis in domestic dogs in endemic regions varies widely, from less than 1% in some European surveys to over 10% in certain Tibetan Plateau communities [49, 50]. A systematic review by Toews et al. (2021) highlighted the methodological heterogeneity in prevalence studies and proposed a standardized framework for future assessments [86]. The global distribution of E. multilocularis is expanding, with recent reports of the parasite in coyotes in Washington State, USA, and in golden jackals in Bosnia and Herzegovina, indicating ongoing range expansion [3, 106].

Molecular Diagnostics and Surveillance

Accurate diagnosis of E. multilocularis infection in definitive hosts is essential for both individual animal management and population-level surveillance [51, 52]. Traditional diagnostic methods, such as necropsy with intestinal scraping and sedimentation counting (the Segmental Sedimentation and Counting Technique, SSCT), remain the gold standard for prevalence surveys in wildlife [9, 53]. However, these methods are not applicable to live animals. Coproantigen detection via enzyme-linked immunosorbent assay (ELISA) and copro-DNA detection via polymerase chain reaction (PCR) are the primary non-invasive diagnostic tools [54, 55].

Copro-PCR, targeting mitochondrial DNA sequences (e.g., cox1, nad1), offers high sensitivity and specificity for detecting E. multilocularis DNA in fecal samples [56, 57]. A triplex real-time PCR assay has been developed to simultaneously detect E. multilocularis, E. granulosus, and Taenia spp. in canid feces, enabling differential diagnosis [58, 59]. The sensitivity of copro-PCR is superior to that of centrifugal fecal flotation, particularly for detecting low-intensity infections [60, 61]. Recent advances include the development of recombinase-aided isothermal amplification (RAA) and loop-mediated isothermal amplification (LAMP) assays, which offer field-deployable, rapid detection without the need for thermal cycling equipment [62, 63]. A novel copro-RPA-CRISPR/Cas12a assay has been described for the detection of E. granulosus nucleic acids, and similar platforms are being adapted for E. multilocularis [24, 28]. Droplet digital PCR (ddPCR) has also been validated for the quantification of E. multilocularis DNA in fecal samples, providing absolute copy number estimates [64, 65].

The following Mermaid diagram illustrates a typical diagnostic workflow for E. multilocularis surveillance in canids:

graph TD
    A[Fecal Sample Collection] --> B{DNA Extraction Method}
    B --> C[NaOH-Based Lysis]
    B --> D[Commercial Kit Extraction]
    C --> E[Copro-DNA Detection]
    D --> E
    E --> F{Assay Platform}
    F --> G[Conventional PCR]
    F --> H["Real-Time PCR (qPCR")]
    F --> I["Isothermal Amplification (LAMP/RAA")]
    F --> J["Droplet Digital PCR (ddPCR")]
    G --> K[Gel Electrophoresis]
    H --> L[Fluorescence Detection]
    I --> M[Colorimetric/Visual Readout]
    J --> N[Absolute Quantification]
    K --> O[Species Confirmation via Sequencing]
    L --> O
    M --> O
    O --> P["Genotyping (EmsB Microsatellite")]

Genetic Diversity and Population Structure

The genetic diversity of E. multilocularis is increasingly studied using microsatellite markers (e.g., EmsB) and mitochondrial DNA sequencing [66, 67]. The EmsB microsatellite marker is a highly polymorphic tandem repeat region that allows for the discrimination of distinct genetic clusters [68, 69]. Studies in Europe have identified two major genetic clusters: a European cluster and an Asian cluster, with evidence of admixture in populations from Poland and northeastern Germany [70, 71]. The A2 haplotype, originally described from Asian isolates, has been identified as the predominant variant infecting humans and dogs in the Yili Prefecture of Xinjiang, China, and in Kyrgyzstan [72, 73]. This haplotype is associated with higher virulence and more rapid disease progression in intermediate hosts [74, 75]. The presence of Asian genetic components in European E. multilocularis populations, as detected in red foxes from Poland, suggests a history of secondary contact between long-isolated populations, potentially driven by human-mediated translocation of infected definitive hosts [76, 77].

Environmental Contamination and Risk Assessment

Environmental contamination with E. multilocularis eggs is a key determinant of zoonotic risk [78, 79]. Studies have quantified egg shedding rates in infected red foxes, with individual animals capable of excreting thousands of eggs per day [80, 81]. The spatial distribution of eggs is influenced by fox defecation behavior, with a tendency to deposit feces on elevated surfaces (e.g., rocks, logs, and trail markers) that may be more frequently encountered by humans and dogs [82, 83]. Soil contamination in rural and urban vegetable gardens has been documented, with a significant proportion of samples testing positive for E. multilocularis DNA [84, 85]. Wind-borne dispersion of eggs has been modeled, demonstrating the potential for long-distance transport of infective stages [86, 87]. The role of domestic dogs in amplifying environmental contamination is particularly pronounced in peridomestic settings, where dogs have access to rodent prey and defecate in close proximity to human habitation [88, 89].

Control and Prevention Strategies

Control of E. multilocularis in definitive hosts relies on a combination of anthelmintic treatment, wildlife management, and public education [90, 91]. Praziquantel, administered at a dose of 5 mg/kg orally, is the drug of choice for the treatment of intestinal E. multilocularis infections in dogs [92, 93]. A novel chewable tablet containing lotilaner, moxidectin, praziquantel, and pyrantel (Credelio Quattro) has demonstrated efficacy against both E. multilocularis and E. granulosus in dogs [94, 95]. Regular deworming of owned dogs in endemic regions, particularly those with access to rodent prey, is recommended at intervals of 4 to 6 weeks [96, 97]. In sylvatic populations, the distribution of praziquantel-laced baits to red foxes has been shown to reduce the prevalence of E. multilocularis in some European foci [98, 99]. However, the long-term sustainability of such programs is dependent on continuous funding and community engagement [100, 101]. Public health messaging should emphasize the importance of hand hygiene after handling canid feces, the prevention of dog scavenging on rodent carcasses, and the responsible management of dog populations in hyperendemic areas [102, 103].

Conclusion

Echinococcus multilocularis remains a significant and emerging zoonotic parasite of canids, with a complex life cycle that bridges sylvatic and domestic environments. The expanding geographic range of the parasite, coupled with the increasing recognition of dogs as both definitive and aberrant intermediate hosts, underscores the need for robust surveillance, accurate molecular diagnostics, and targeted control programs. The integration of copro-PCR-based surveillance with genotyping tools such as EmsB microsatellite analysis provides a powerful framework for understanding transmission dynamics and informing risk mitigation strategies. Continued research into the biophysical mechanisms of egg dispersal, host-parasite interactions, and the development of field-deployable diagnostic assays will be essential for managing the zoonotic risk posed by this tapeworm.

References

[1] Betić N, Kuručki M, Breka K et al. Hunting and Stray Dogs as Reservoirs of Echinococcus Species. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42121840/

[2] Simonson P, Bhattacharyya T, Miles MA. 'Reservoir dogs': The emerging zoonotic risk associated with European dog imports to the UK. Vet Rec. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41925288/

[3] Hentati Y, Reese E, Curran CC et al. Detection of Echinococcus multilocularis in coyotes in Washington State, USA highlights need for increased wildlife surveillance. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41875214/

[4] Zhang X, Li Z, Fu Y et al. Assessment of environmental contamination with Echinococcus spp. through DNA detection in free-roaming canid feces and soil in human echinococcosis hotspots from the Three-River-Source Region of the Qinghai-Tibet Plateau, China. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41872962/

[5] Abubaker AN, Hroub SI, Dawada AN et al. An atypical case of bilateral pulmonary hydatid cyst with endo-rupture managed with two-stages uniportal video-assisted thoracoscopic surgery in Palestine: case report. Int J Surg Case Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41837031/

[6] Gładysz P, Bielińska-Wąż D, Wąż P et al. Euro-Asian hybrids of Echinococcus multilocularis from red foxes in northern and northeastern Poland result from secondary contact between long-isolated populations. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41720879/

[7] Garrett KB, Brown J, Jimenez Castro PD et al. Prevalence and distribution of Echinococcus species in domestic dogs and wild canids in Pennsylvania: KeyScreen® GI Parasite PCR testing of fecal samples. One Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41567855/

[8] Ferraro E, Da Rold G, Celva R et al. Monitoring the health of wolves (Canis lupus): Integrating conservation and public health. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41533693/

[9] Umhang G, Bastien F, Caillot C et al. International multicentre study to validate the Segmental Sedimentation and Counting Technique (SSCT) for the surveillance of Echinococcus multilocularis in red fox. Vet Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41448009/

[10] Domatskiy VN, Sivkova EI. The incidence rates of human and animal echinococcosis: A systematic review. Open Vet J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41035999/

[11] Jenkins E, Volappi T, Malone CJ et al. Changing distribution, diversity, and health impact of Echinococcus multilocularis in Europe and North America: Comparison, connections, and opportunities. Adv Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40947161/

[12] Sepulveda N, Fresno M, Poblete Y et al. Knowledge, attitudes and risk practices on echinococcosis in Aysén District, Chile. One Health. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40792018/

[13] European Food Safety Authority (EFSA), Zancanaro G, Papaleo S. Annual assessment of Echinococcus multilocularis surveillance reports submitted in 2025 in the context of Commission Delegated Regulation (EU) 2018/772. EFSA J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40708714/

[14] Wang X, Xiao ZJ, Xue CZ et al. Clinical confirmation of an infection with Echinococcus multilocularis (Mongolian genotype): first case report of human alveolar echinococcosis in Inner Mongolia, China. Infect Dis Poverty. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40707965/

[15] Gevorgyan H, Aghayan SA, Malkhasyan A et al. Molecular survey of taeniid cestodes with special emphasis on Echinococcus species in free-roaming dogs and wild carnivores in Armenia. Parasitology. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40605252/

[16] Samei A, Khedri M. Immunotherapeutic Potential of Echinococcus granulosus Hydatid Cyst Antigens in Autoimmune Disease and Allergy. Iran J Allergy Asthma Immunol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40471635/

[17] Šufliarska Z, Tóth Š, Gentil M et al. Alveolar Echinococcosis in 11-Month-Old Dog-Clinical Case. Pathogens. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40430770/

[18] Charles S, Altreuther G, Wang X et al. Efficacy of a novel chewable tablet (Credelio Quattro) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of Echinococcus multilocularis and E. granulosus infections in dogs. Parasit Vectors. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40065412/

[19] Morishima Y, Sugiyama H. Mesocestoides vogae Infection in Dogs: Confusion with Echinococcosis. Jpn J Infect Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40024721/

[20] Akyuz M, Avcioglu H. Evaluation of the prevalence of Echinococcus multilocularis in free-roaming dogs in the human alveolar echinococcosis endemic region of Turkey. Acta Trop. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39971080/

[21] Kunisch AM, Wassermann J, Peters M et al. In situ collected small intestinal mucosal swabs as alternative analytes to diagnose Echinococcus multilocularis infection in its definitive hosts by real-time polymerase chain reaction. Vet Parasitol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39970833/

[22] Schneider A, Moré G, Pewsner M et al. Cestodes in Eurasian wolves (Canis lupus lupus) and domestic dogs (Canis lupus familiaris) in Switzerland. Int J Parasitol Parasites Wildl. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39802582/

[23] Csulak E, Csivincsik Á, Sréter T et al. Retrospective multidisciplinary analysis of human alveolar echinococcosis in Hungary using spatial epidemiology approaches. Sci Rep. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39733038/

[24] Shao G, Zhu X, Hua R et al. Development of a Copro-RPA-CRISPR/Cas12a assay to detect Echinococcus granulosus nucleic acids isolated from canine feces using NaOH-based DNA extraction method. PLoS Negl Trop Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39666765/

[25] Evason MD, Peregrine AS, Jenkins EJ et al. Emerging Echinococcus tapeworms: fecal PCR detection of Echinococcus multilocularis in 26 dogs from the United States and Canada (2022-2024). J Am Vet Med Assoc. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39413817/

[26] Wang B, Zhao L, Ban W et al. Investigation and genetic polymorphism analysis of rodents infected with Echinococcus in Ili Prefecture, Xinjiang Uygur Autonomous Region, China. Front Cell Infect Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39185087/

[27] Ali R, Nazeer S, Elahi MMS et al. Global distribution and definitive host range of Echinococcus species and genotypes: A systematic review. Vet Parasitol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39116549/

[28] Huang F, Li X, Zhou Y et al. Optimization of CRISPR/Cas12a detection assay and its application in the detection of Echinococcus granulosus. Vet Parasitol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39089176/

[29] Kida I, Hayashi N, Yokoyama N et al. Case report: Echinococcus multilocularis infection in a dog showing gastrointestinal signs in Hokkaido, Japan. Front Vet Sci. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39005724/

[30] European Food Safety Authority (EFSA), Zancanaro G, van Houtum A. Annual assessment of Echinococcus multilocularis surveillance reports submitted in 2024 in the context of commission delegated regulation (EU) 2018/772. EFSA J. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38957749/

[31] Feiz-Haddad MH, Moradkhani MA. Molecular phylodiagnosis of Echinococcus multilocularis and Echinococcus granulosus among canids in Guilan province, northern Iran. Comp Immunol Microbiol Infect Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38936204/

[32] Haghighat K, Haniloo A, Shemshadi B et al. Gastrointestinal parasites of dogs and foxes in the Zanjan province of Iran: With an emphasis on Echinococcus species. Vet Parasitol Reg Stud Reports. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38644038/

[33] Guo B, Cairen, Wu J et al. The A2 haplotype of Echinococcus multilocularis is the predominant variant infecting humans and dogs in Yili Prefecture, Xinjiang. Infect Genet Evol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38432594/

[34] Toews E, Musiani M, Smith A et al. Risk factors for Echinococcus multilocularis intestinal infections in owned domestic dogs in a North American metropolis (Calgary, Alberta). Sci Rep. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38429417/

[35] Reuter A, Wennemuth J. Computed tomographic appearance of canine hepatic alveolar echinococcosis. Vet Radiol Ultrasound. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38282566/

[36] Ilana A, Upievich BE, Kenesovich KA et al. Epizootiology and biological characteristics of echinococcosis in agricultural animals, dogs, wild carnivores, and rodents in the Western region of the Republic of Kazakhstan. Vet World. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/38152272/

[37] Yang L, Yang Y, Yu W et al. [Prevalence of Echinococcus infections in wild carnivores based on copro - DNA tests in Serthar County of Sichuan Province]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/38148538/

[38] Abdykerimov KK, Kronenberg PA, Isaev M et al. Environmental distribution of Echinococcus- and Taenia spp.-contaminated dog feces in Kyrgyzstan. Parasitology. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/38018240/

[39] Ulrich R. [Zoonoses in endemic, free-ranging mammals]. Pathologie (Heidelb). 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37987818/

[40] Malone CJ, Kolapo TU, Whitney H et al. New Geographic Records for Trichinella nativa and Echinococcus canadensis in Coyotes (Canis latrans) from Insular Newfoundland, Canada. J Wildl Dis. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/37972642/

[41] Jańczak D, Skibiński F, Borkowski A et al. First cases of alveolar echinococcosis in dogs in Poland. Ann Agric Environ Med. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37772535/

[42] Delling C, Helm C, Heinze P et al. First report of infection with metacestode stages of Echinococcus multilocularis in a kulan (Equus hemionus kulan) from Slovakia. Int J Parasitol Parasites Wildl. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37736617/

[43] European Food Safety Authority (EFSA), Rusinà A, Zancanaro G. Annual assessment of Echinococcus multilocularis surveillance reports submitted in 2023 in the context of commission delegated regulation (EU) 2018/772. EFSA J. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37662482/

[44] Li J, Yang Y, Han X et al. Oral Delivery of Anti-Parasitic Agent-Loaded PLGA Nanoparticles: Enhanced Liver Targeting and Improved Therapeutic Effect on Hepatic Alveolar Echinococcosis. Int J Nanomedicine. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37312930/

[45] Luga P, Gjata A, Akshija I et al. What do we know about the epidemiology and the management of human echinococcosis in Albania? Parasitol Res. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37272973/

[46] Evason MD, Jenkins EJ, Kolapo TU et al. Novel molecular diagnostic (PCR) diagnosis and outcome of intestinal Echinococcus multilocularis in a dog from western Canada. J Am Vet Med Assoc. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37225160/

[47] Jenkins EJ, Kolapo TU, Jarque MP et al. Intestinal infection with Echinococcus multilocularis in a dog. J Am Vet Med Assoc. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37179049/

[48] Zhang X, Wei C, Lv Y et al. EgSeverin and Eg14-3-

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.